Stockreport

Pipeline Moves: Alnylam's Amvuttra approval prospects up after Phase III win [Yahoo! Finance]

Alnylam Pharmaceuticals, Inc.  (ALNY) 
Last alnylam pharmaceuticals, inc. earnings: 2/6 08:00 am Check Earnings Report
US:NASDAQ Investor Relations: investors.alnylam.com/investor-overview
PDF Meanwhile, Junshi Biosciences's toripalimab saw a Phase II investigator-led ovarian cancer trial suspended. On a positive note, Shiongi's S-309309 reported a Phase II [Read more]